499 related articles for article (PubMed ID: 30639549)
1. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
3. Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
Ann Thorac Cardiovasc Surg; 2018 Apr; 24(2):81-88. PubMed ID: 29367501
[TBL] [Abstract][Full Text] [Related]
4. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
5. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742
[TBL] [Abstract][Full Text] [Related]
6. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
7. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
[TBL] [Abstract][Full Text] [Related]
9. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
[TBL] [Abstract][Full Text] [Related]
12. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
Flores RM
Semin Thorac Cardiovasc Surg; 2009; 21(2):149-53. PubMed ID: 19822286
[TBL] [Abstract][Full Text] [Related]
13. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
14. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
[TBL] [Abstract][Full Text] [Related]
15. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
[TBL] [Abstract][Full Text] [Related]
16. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients.
Sugarbaker DJ; Richards WG; Bueno R
Ann Surg; 2014 Oct; 260(4):577-80; discussion 580-2. PubMed ID: 25203873
[TBL] [Abstract][Full Text] [Related]
17. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
[TBL] [Abstract][Full Text] [Related]
18. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
Wolf AS; Daniel J; Sugarbaker DJ
Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
[TBL] [Abstract][Full Text] [Related]
19. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
[TBL] [Abstract][Full Text] [Related]
20. Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma.
Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Ahiskali R; Bozkurtlar E; Bekiroglu N; Lacin T; Yildizeli B; Yuksel M
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2724-2733. PubMed ID: 29510939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]